Advertisement
argenx SE

argenx SE (ARGX) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

ARGX●NASDAQ
HealthcareBiotechnology
$842.27
$29.13(3.58%)
U.S. Market opens in 16h 6m
Advertisement

argenx SE (ARGX)

Meyka AI Score

Z

Key Financials

Market Cap52.1B
P/E Ratio21.45
EPS (TTM)$22.53
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$695.48
3 Months$774.20
1 Year Target$821.95

ARGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $821.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.45 and a market capitalization of 52.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.58%
5-Day Change
0.45%
1-Month Change
3.84%
3-Month Change
12.37%
6-Month Change
-8.05%
Year-to-Date (YTD) Change
0.16%
1-Year Change
46.86%
3-Year Change
109.15%
5-Year Change
212.03%
All-Time (Max) Change
3562.04%

Contact Information

https://www.argenx.com
31 10 703 8441
Laarderhoogtweg 25, Amsterdam, NaN, 1101EB

Company Facts

1,599 Employees
IPO DateMay 18, 2017
CountryNL
Actively Trading

Frequently Asked Questions